ABN AMRO Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
8,568
-429,772
-98% -$23.3M ﹤0.01% 206
2026
Q1
$27.7M Sell
438,340
-134,842
-24% -$10.8M 0.3% 58
2025
Q4
$54.6M Buy
573,182
+490,983
+597% +$48.1M 0.51% 42
2025
Q3
$7.98M Buy
82,199
+33,418
+69% +$3.46M 0.08% 97
2025
Q2
$5.26M Buy
48,781
+30,113
+161% +$3.05M 0.07% 88
2025
Q1
$1.88M Sell
18,668
-2,439
-12% -$246K 0.03% 101
2024
Q4
$1.86M Sell
21,107
-155
-0.7% -$13.6K 0.03% 107
2024
Q3
$1.77M Sell
21,262
-2,398
-10% -$189K 0.02% 108
2024
Q2
$1.84M Sell
23,660
-2,766
-10% -$202K 0.03% 93
2024
Q1
$1.81M Sell
26,426
-1,834
-6% -$118K 0.03% 93
2023
Q4
$1.64M Buy
28,260
+1,692
+6% +$90.3K 0.03% 95
2023
Q3
$1.4M Buy
+26,568
New +$1.39M 0.03% 99

Other funds holding BSX

ABN AMRO Bank's BSX Position: Q2 2026 in Review

ABN AMRO Bank reduced its Boston Scientific (BSX) stake by 98% in Q2 2026, selling an estimated $23.3M and leaving 8,568 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

ABN AMRO Bank first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $54.6M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • ABN AMRO Bank held 8,568 shares of Boston Scientific worth $372K as of Q2 2026.
  • ABN AMRO Bank sold 429,772 Boston Scientific shares in Q2 2026, an estimated $23.3M.
  • Boston Scientific made up ﹤0.01% of ABN AMRO Bank's portfolio in Q2 2026, its #206 holding.
  • ABN AMRO Bank first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • ABN AMRO Bank's Boston Scientific position peaked at $54.6M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.